ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butterworth, J.
Right arrow Articles by James, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butterworth, J.
Right arrow Articles by James, R. L.
Related Collections
Right arrow Extracorporeal circulation

Ann Thorac Surg 2002;74:1589-1595
© 2002 The Society of Thoracic Surgeons


Original article: cardiovascular

Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass

John Butterworth, MDa*, Yonggu A. Lin, MSa, Richard C. Prielipp, MD, FCCMa, Judy Bennett, RNa, John W. Hammon, MDb, Robert L. James, MStata

a Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
b Department of Cardiothoracic Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA

Accepted for publication July 11, 2002.

* Address reprint requests to Dr Butterworth, Department of Anesthesiology, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1009, USA.
e-mail: jbutter{at}wfubmc.edu

BACKGROUND: Despite long use of protamine in cardiac operations, neither protamine concentrations nor pharmacokinetics have been reported in patients.

METHODS: Twenty-eight patients (age, 26 to 80 years) undergoing various cardiac surgical procedures gave their consent to receive 250 mg of protamine sulfate administered intravenously by an infusion pump during 5 minutes. Protamine was administered at the usual intraoperative time after separation from cardiopulmonary bypass for reversal of heparin. Timed arterial blood samples were obtained after protamine infusion. Blood plasma was subjected to solid-phase extraction and high-performance liquid chromatography. Total (free + heparin-bound) protamine concentration versus time data were subjected to pharmacokinetic modeling.

RESULTS: Twenty-six patients completed the study. Total plasma protamine concentrations declined rapidly. Model-independent pharmacokinetic analysis revealed median (range) values as follows: volume of distribution, 5.4 L (0.82 to 34 L); clearance, 1.4 L/min (0.61 to 3.8 L/min); and half-life, 4.5 min (1.9 to 18 min). Schwarz-Bayesian criterion identified a two-compartment exponential model with adjustment for weight in the central compartment volume of distribution as performing better than other compartmental or Michaelis-Menten models.

CONCLUSIONS: Protamine has a very short (approximately 5 minutes) half-life after a single 250-mg dose in adult patients. This short half-life could underlie recurrent anticoagulation after initial apparent reversal of heparin.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Dunning, M. Versteegh, A. Fabbri, A. Pavie, P. Kolh, U. Lockowandt, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 73 - 92.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. F. Merry
Focus on Thrombin: Alternative Anticoagulants
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2007; 11(4): 256 - 260.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. G. Nielsen
Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1720 - 1727.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. O'Connor, A. Kells, S. Henry, and T. Scalea
Vacuum-Assisted Closure for the Treatment of Complex Chest Wounds
Ann. Thorac. Surg., April 1, 2005; 79(4): 1196 - 1200.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. H. T. Teoh, E. Young, M. H. Blackall, R. S. Roberts, and J. Hirsh
Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 211 - 219.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. F. Merry, P. J. Raudkivi, N. G. Middleton, J. M. McDougall, P. Nand, B. P. Mills, B. J. Webber, C. M. Frampton, and H. D. White
Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery
Ann. Thorac. Surg., March 1, 2004; 77(3): 925 - 931.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
K. E. Mclaughlin and J. Dunning
In patients post cardiac surgery do high doses of protamine cause increased bleeding?
Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 424 - 426.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.